跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Omnipaque 240 10.36g/20mL Injection Vial
Approved
STANDARD
Omnipaque 240 10.36g/20mL Injection Vial
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
db9c61999bda8111
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
db9c61999bda8111
Product Name
Omnipaque 240 10.36g/20mL Injection Vial
Artg Id
48217
Artg Name
OMNIPAQUE 240 iohexol 10.36g/20mL injection vial
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
1994-03-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-01629-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-01628-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
db9c61999bda8111
Type
Standard
Back to TGA Approvals
Omnipaque 240 10.36g/20mL Injection Vial - TGA Drug Approval Details